Biaxin Transition: XL Accounts For 65% Of Franchise Sales
This article was originally published in The Pink Sheet Daily
Executive Summary
Biaxin XL (extended-release clarithromycin) accounts for approximately 65% of sales of the Biaxin franchise, Abbott said Jan. 18